Cargando…

Alternative Splicing and Tumor Progression

Alternative splicing is a key molecular mechanism for increasing the functional diversity of the eukaryotic proteomes. A large body of experimental data implicates aberrant splicing in various human diseases, including cancer. Both mutations in cis-acting splicing elements and alterations in the exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghigna, Claudia, Valacca, Cristina, Biamonti, Giuseppe
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers Ltd 2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694562/ https://www.ncbi.nlm.nih.gov/pubmed/19516963 http://dx.doi.org/10.2174/138920208786847971

Ejemplares similares

Sam68 regulates EMT through alternative splicing–activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene
por: Valacca, Cristina, et al.
Publicado: (2010)

Oncogenic Alternative Splicing Switches: Role in Cancer Progression and Prospects for Therapy
por: Bonomi, Serena, et al.
Publicado: (2013)

Alternative Splicing: Role in Cancer Development and Progression
por: Sette, Claudio, et al.
Publicado: (2013)

Alternative Splicing and Cancer
por: Auboeuf, Didier, et al.
Publicado: (2012)

EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression
por: Pradella, Davide, et al.
Publicado: (2017)

Alternative Splicing: Recent Insights into Mechanisms and Functional Roles
por: Ghigna, Claudia, et al.
Publicado: (2020)

HnRNP A1 controls a splicing regulatory circuit promoting mesenchymal-to-epithelial transition
por: Bonomi, Serena, et al.
Publicado: (2013)

An Intricate Connection between Alternative Splicing and Phenotypic Plasticity in Development and Cancer
por: Biamonti, Giuseppe, et al.
Publicado: (2019)

The Krebs Cycle Connection: Reciprocal Influence Between Alternative Splicing Programs and Cell Metabolism
por: Biamonti, Giuseppe, et al.
Publicado: (2018)

Diversification of the muscle proteome through alternative splicing
por: Nakka, Kiran, et al.
Publicado: (2018)

The alternative splicing factor Nova2 regulates vascular development and lumen formation
por: Giampietro, Costanza, et al.
Publicado: (2015)

Regulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in Cancer
por: Siegfried, Zahava, et al.
Publicado: (2013)

Alternative splicing in endothelial cells: novel therapeutic opportunities in cancer angiogenesis
por: Di Matteo, Anna, et al.
Publicado: (2020)

Relative strength of 5’ splice-site strength defines functions of SRSF2 and SRSF6 in alternative splicing of Bcl-x pre-mRNA
por: Choi, Namjeong, et al.
Publicado: (2021)

Widespread Alternative Splicing Changes in Metastatic Breast Cancer Cells
por: Oh, Jagyeong, et al.
Publicado: (2021)

Global Alternative Splicing Defects in Human Breast Cancer Cells
por: Oh, Jagyeong, et al.
Publicado: (2021)

Transcription of Satellite III non-coding RNAs is a general stress response in human cells
por: Valgardsdottir, Rut, et al.
Publicado: (2008)

Gene Expression Profiles Controlled by the Alternative Splicing Factor Nova2 in Endothelial Cells
por: Belloni, Elisa, et al.
Publicado: (2019)

A 2-nt RNA enhancer on exon 11 promotes exon 11 inclusion of the Ron proto-oncogene
por: MOON, HEEGYUM, et al.
Publicado: (2014)

Characterization of progression-related alternative splicing events in testicular germ cell tumors
por: Zhang, Chuan-Jie, et al.
Publicado: (2020)

Alternative Splicing Changes Promoted by NOVA2 Upregulation in Endothelial Cells and Relevance for Gastric Cancer
por: Di Matteo, Anna, et al.
Publicado: (2023)

Tumor microenvironment–associated modifications of alternative splicing
por: Brosseau, Jean-Philippe, et al.
Publicado: (2014)

Identification and validation of critical alternative splicing events and splicing factors in gastric cancer progression
por: Feng, Haoran, et al.
Publicado: (2020)

TIMP-2 Interaction with MT1-MMP Activates the AKT Pathway and Protects Tumor Cells from Apoptosis
por: Valacca, Cristina, et al.
Publicado: (2015)

Splicing and alternative splicing in rice and humans
por: E, Zhiguo, et al.
Publicado: (2013)

The Roles of Alternative Splicing in Tumor-immune Cell Interactions
por: Wang, Yue, et al.
Publicado: (2020)

TRA2: The dominant power of alternative splicing in tumors
por: Xue, Jiancheng, et al.
Publicado: (2023)

Alternative Splice in Alternative Lice
por: Tovar-Corona, Jaime M., et al.
Publicado: (2015)

The role of alternative pre-mRNA splicing in cancer progression
por: Choi, Sunkyung, et al.
Publicado: (2023)

Diverse alternative back-splicing and alternative splicing landscape of circular RNAs
por: Zhang, Xiao-Ou, et al.
Publicado: (2016)

Alternative splicing in cardiomyopathy
por: Beqqali, A.
Publicado: (2018)

Alternative Splicing in Angiogenesis
por: Bowler, Elizabeth, et al.
Publicado: (2019)

An extensive program of periodic alternative splicing linked to cell cycle progression
por: Dominguez, Daniel, et al.
Publicado: (2016)

Melatonin inhibits HCC progression through regulating the alternative splicing of NEMO
por: Bai, Lu, et al.
Publicado: (2022)

Alternative splicing regulation at tandem 3′ splice sites
por: Akerman, Martin, et al.
Publicado: (2006)

Protein Modularity of Alternatively Spliced Exons Is Associated with Tissue-Specific Regulation of Alternative Splicing
por: Xing, Yi, et al.
Publicado: (2005)

Cleavage and Polyadenylation Specific Factor 1 Promotes Tumor Progression via Alternative Polyadenylation and Splicing in Hepatocellular Carcinoma
por: Chen, Shi-lu, et al.
Publicado: (2021)

Alternative splicing regulation in tumor necrosis factor-mediated inflammation
por: López-Urrutia, Eduardo, et al.
Publicado: (2017)

Alternative Splicing Events in Tumor Immune Infiltration in Colorectal Cancer
por: Shi, Jian-yu, et al.
Publicado: (2021)

Opposite Roles of Tra2β and SRSF9 in the v10 Exon Splicing of CD44
por: Oh, Jagyeong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_if319c2chlsf691hhn6ib7evaf